Development of a secretable frataxin for Friedrich’s ataxia with Dr. Dan DuBreuil

0:00-19:49

In this episode, recorded on-site at the ASGCT 2026 Annual Meeting, Molecular Therapy Advances Associate Editor-in-Chief Dr. Dan Stone speaks with Dr. Dan DuBreuil of Sanofi. They break down the science behind a recent paper detailing the development of a secretable frataxin, highlighting its potential to improve treatment efficacy for Friedreich’s ataxia. Music: 'Electric Dreams' by Scott Buckley - released under CC-BY 4.0. www.scottbuckley.com.auShow your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

Publisher

ASGCT Podcast Network

Link

omny.fm/shows/asgct-podcast-network/development-of-a-secretable-frataxin-for-friedrich-s-ataxia-with-dr-dan-dubreuil

Published

June 4, 2026

Duration

20 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

American Society of Gene & Cell Therapy

AP

ASGCT Podcast Network

@asgctpodcastnetwork

#secretablefrataxin #friedrichsataxia #dandubreuil #lifesciences #chemistry #medicine

The Nile